Latest news with #Quipt
Toronto Star
3 days ago
- Business
- Toronto Star
Quipt Home Medical Partners With Three Major Health Systems to Form Strategic Joint Venture
CINCINNATI, Aug. 12, 2025 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. ('Quipt' or the 'Company') (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced it has signed a definitive agreement with three major health systems and hospitals to form a joint venture. Pursuant to the definitive agreement, Quipt will acquire a 60% ownership interest in Hart Medical Equipment ('Hart'), with the remaining 40% interest collectively held by major health systems, Henry Ford Health, McLaren Health Care, Blanchard Valley Health System, Wood County Hospital and The Bellevue Hospital. This strategic transaction is expected to enhance Quipt's presence in the Midwest, add deep healthcare system partnerships, and provide the Company with immediate entry into Michigan, a large and strategically important market, and new territories in Ohio.
Toronto Star
3 days ago
- Business
- Toronto Star
Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results
Posts Positive Organic Growth and Adjusted EBITDA 1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. ('Quipt' or the 'Company') (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal third quarter 2025 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2025, and are reported in United States dollars.
Business Wire
22-06-2025
- Business
- Business Wire
QIPT Investors Have Opportunity to Join Quipt Home Medical Corp. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quipt Home Medical Corp. ('Quipt' or 'the Company') (NASDAQ: QIPT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. One of Quipt's largest shareholders, Forager Capital Management ("Forager"), issued a press release on June 5, 2025, requesting that the Company 'immediately and unequivocally retract its false and misleading statement made in its press release on May 21, 2025 relating to Forager's offer to acquire 100% of Quipt's issued and outstanding common shares at a price of $3.10 per common share." Based on this news, shares of Quipt fell by more than 8.5% on the same day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Yahoo
05-06-2025
- Business
- Yahoo
Forager requests Quipt Home Medical terminate standstill agreement
Forager said, 'Forager Capital Management, one of the largest shareholders of Quipt Home Medical (QIPT) Corp., requests that Quipt immediately and unequivocally retract its false and misleading statement made in its press release on May 21, 2025 relating to Forager's offer to acquire 100% of Quipt's issued and outstanding common shares at a price of $3.10 per common share. Forager's priority is value crystallization for shareholders and correcting misinformation-not engaging in a public dispute with Quipt. Quipt's characterization of Forager's May 17, 2025 Letter of Intent as 'unsolicited' is disingenuous. Section 9 of the Non-Disclosure and Standstill Agreement entered on February 1, 2025 states that Forager is permitted to make an offer with advance written notice from the Quipt Board of Directors. Forager received an email from the Chairman of the Board of Directors on May 15, 2025 inviting Forager to access additional data so it could make its best offer. Forager determined it had sufficient data to formulate its offer and interpreted the Chairman's email as a good-faith invitation to engage and responded accordingly. Moreover, Forager gave the Board prompt notice pursuant to Section 6 of the Agreement to which Forager never received any objection. Quipt is using Section 9 of the Agreement to paint Forager as a bad actor and to suggest to shareholders that Forager is prohibited from making an offer, while simultaneously using Section 1 to prevent Forager from disclosing relevant, material facts to those same shareholders. Shareholders deserve the opportunity to receive and evaluate all offers that increase shareholder value. Forager requests that Quipt terminate the Agreement. This request is costless and overwhelmingly in the best interest of shareholders.' Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on QIPT: Disclaimer & DisclosureReport an Issue Quipt Home Medical Receives Acquisition Proposal from Forager Quipt Home Medical confirms receipt of unsolicited acquisition proposal Quipt Home Medical: Hold Rating Amid Growth Challenges and Sector Headwinds Quipt Home Medical Corp's Mixed Earnings Call Analysis Quipt Home Medical price target lowered to $4 from $6 at Benchmark Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Market Online
21-05-2025
- Business
- The Market Online
Quipt Home Medical addresses hostile takeover bid
Quipt Home Medical (TSX:QIPT) has acknowledged a hostile takeover proposal from Forager Capital Management at C$3.10 per share Quipt specializes in in-home monitoring and disease management services in the United States healthcare market Quipt Home Medical stock has given back 30.72 per cent year-over-year and 28.57 per cent since 2020 Quipt Home Medical (TSX:QIPT), a US home medical equipment provider focused on respiratory care, has acknowledged a hostile takeover proposal from Forager Capital Management at C$3.10 per share. The acknowledgement, prompted by Forager's public bid, follows a non-disclosure and standstill agreement from February 1, 2025, under which Forager agreed to abstain from acquiring Quipt equity or assets for six months without approval from the company's board. According to Wednesday's news release, Quipt's board did not authorize Forager to break confidentiality or issue the non-binding proposal. 'The board remains focused on the best long-term interests of the company to drive sustainable value for its shareholders,' the news release goes on to state, with financial and legal advisory ongoing, though no further comments on the proposal will be issued unless required by law. Quipt more than tripled revenue from US$72.64 million in 2020 to US$245.94 million in 2024, generating positive operating income in 4 of 5 years over the period. Net income, however, has been elusive, with the company posting a positive number under the metric in only one year since 2020. About Quipt Home Medical Quipt specializes in in-home monitoring and disease management services in the United States healthcare market. Quipt Home Medical stock (TSX:QIPT) last traded at C$3. The stock has given back 30.72 per cent year-over-year and 28.57 per cent since 2020. Join the discussion: Find out what everybody's saying about this medical device stock on the Quipt Home Medical Corp. Bullboard and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
